Moxidectin interference on motor activity of rats by RODRIGUES-ALVES, Patrícia de Sá e Benevides et al.
883 
Braz. Arch. Biol. Technol. v.52 n.4: pp. 883-891, July/Aug 2009 
Vol.52, n. 4: pp.883-891, July-August 2009 
ISSN 1516-8913    Printed in Brazil 
 BRAZILIAN ARCHIVES OF  
BIOLOGY AND TECHNOLOGY 
  
A N  I N T E R N A T I O N A L  J O U R N A L  
 
 
 
Moxidectin Interference on Motor Activity of Rats 
 
Patrícia de Sá e Benevides Rodrigues-Alves1, Jorge Camilo Flório 2, Ivo Lebrun 3, Maria 
Martha Bernardi 2 and Helenice de Souza Spinosa2* 
1Instituto de Psicologia; Universidade de São Paulo; SP - Brasil. 2Departamento de Patologia, Faculdade de 
Medicina Veterinária e Zootecnia; Universidade de São Paulo; Av. Prof. Dr. Orlando Marques de Paiva, 87; 
05508-900; São Paulo - SP - Brasil. 3Instituto Butantan - SP - Brasil 
 
 
 
ABSTRACT 
 
The present study investigated the effects of the moxidectin (MXD) in some parameters of rat motor function and 
neurochemical. The general activity in the open field and the motor coordination in the wooden beam were 
employed to evaluate the MXD effects. The results showed that, in the open field, even at high doses (2.0 and 20.0 
mg/kg), the MXD did not alter the locomotion and the rearing frequencies. However, MXD was able to impair the 
motor coordination of the animals at wooden beam. Neurochemical studies of striatal GABA and dopamine 
neurotransmitters showed a reduced levels of dopamine and its metabolite, homovanillic acid, without interference 
on striatal GABA levels. Since GABAergic receptor stimulation had an inhibitory effect on dopaminergic striatal 
system, the decreased motor coordination could be attributed to an action of MXD on dopamine system via GABA 
activation. 
 
Key words: Moxidectin, GABA, motor coordination, rat, open field, wooden beam 
 
 
                                                 
*
 Author for correspondence: hspinosa@usp.br 
INTRODUCTION 
 
Moxidectin (MXD) is a milbemycin compound 
produced by a combination of fermentation and 
chemicals synthesis. MXD is obtained by chemical 
modification of nemadectin, the natural compound 
is produced when Streptomyces cianogriseus is 
ground under controlled culture conditions 
(Takigushi et al., 1980). The milbemycins were 
discovered in 1973, as acaricidal and insecticidal 
compounds for   crop protection by   Sankyo 
scientists   and their  name   reflected    this    
(milbe mite + myc    fungus +   in pharmaceutical  
product) (Campbell, 1989; Steel, 1993; Shoop et 
al.,1995; Lanusse et al. 1997). The mylbemicins 
anthelmintics have a broad-spectrum activity 
against internal and external parasites in animals. 
MDX is a milbemycin endectocide compound 
active at extremely low dosages against a wide 
variety of nematode and arthropod parasites of 
domestic animals (Campbell, 1989; Lifschitz et al., 
2002; Njue et al., 2004). 
Milbemicyn and avermectins (AVM) are highly 
lipophilic substances that dissolve in most organic 
solvents, and MXD solubility in water is 4.3mg/L. 
Their high lipophilicity accounts for a wide tissue 
distribution and long residence in plasma, and 
allows these substances to cross the cellular 
barriers (Lanusse et al., 1997). After treatment, 
this drug is found mainly in liver and fat (Molento 
et al., 2004). 
MXD peak plasma concentration (Cmax) were 
achieved 8h post-treatment (subcutaneous 
administration of 200µg/kg to cattle), and the 
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concentration of MXD in fat after 28 days of 
treatment in cattle has been shown to be ninety-
fold higher than that detected in plasma. A great 
proportion of MXD parent drug would accumulate 
in fat, such phenomenon explaining the long 
plasma residence time obtained for this drug, after 
an early peak concentration followed by a fast 
decline (distribution phase) in the plasma 
concentration profile between the Cmax and 10 days 
post-treatment (Lanusse et al., 1997). When 
administered orally to ovine and rats, this peak 
will be of 10 hours (Joint FAO/WHO, 1995). 
MXD showed moderate toxicity when 
administered orally to rats and mice (50% lethal 
dose (LD 50) 50-100 mg/kg (Joint FAO/WHO, 
1995). When MXD is administered to the animals 
in high doses, the adverse effects observed are 
characterized by neurotoxicity signs as depression, 
ataxia, tremors, anxiety, vision difficulty, coma 
and death. 
Although the antiparasitic activity of the 
milbemycins has been described since more than 
two decades, its mechanism of action is still not 
totally elucidated. The main difficulty is due to 
controversial studies performed in different 
biological systems with different methodologies, 
which provides inconclusive data. In this respect, 
studies about the AVM’s mechanism of action are 
more abundant than those of the milbemycins. The 
molecular structures of the two groups of so-called 
‘endectocide’ compounds are superimposable 
(Shoop et al., 1995). They share some structural 
and physicochemical properties, and their broad-
spectrum antiparasitic activity against nematodes 
and arthropods at extremely low dosage rates 
(Steel, 1993) is based on a common mode of 
action (Shoop et al., 1995; Lanusse et al., 1997; 
Fisher and Mrozik, 1989; Turner and Schaeffer; 
1989; Arena et al., 1991, 1992, and 1995; Roder, 
1998; Spinosa et al., 1999 and 2002; Forrester et 
al., 2002). 
MXD and ivermectin are believed to act by 
binding to glutamate- and gamma-aminobutyric 
acid (GABA)-gated chloride channels, resulting in 
somatic and pharyngeal muscle paralysis of the 
parasite, respectively (Duce and Scott, 1985; 
Dawson et al., 2000; Feng et al., 2002; Lifschitz et 
al, 2002; Molento et al.,2004; Njue et al, 2004). In 
the insects and arthropods, the AVMs interfere at 
the transmission among nervous and muscular 
cells, because the GABAergic receptors are 
located at the neuromuscular junction. These 
inhibitory receptors are found only in invertebrates 
(insects, crustaceans and nematodes) and belong to 
the superfamily of ligand-gated ion channels 
(Arena, 1994; Cleland, 1996; Cully et al., 1996; 
Njue et al., 2004). AVMs also interact with GABA 
receptors in brain of vertebrates (mammals), but 
its affinity for the invertebrate animals receptor is 
approximately 100 times greater (Schaeffer and 
Haines, 1989).  
Thus, most of the studies accomplished on the 
mechanism of action of the macrocyclic lactones 
in mammals involve the GABA neurotransmitter, 
since this neurotransmitter has an important role in 
the regulation of the motor activity (Agmo and 
Giordano, 1985; Tegnér et al., 1993; Kriem et al., 
1998). The goal of the current study was to 
evaluate the possible effects of the MXD in the 
general activity of rats observed in the open field 
and in their motor coordination at the wooden 
beam. Also, neurochemical analysis of striatal 
GABA and dopamine neurotransmitters were 
performed. 
 
 
MATERIAL AND METHODS 
 
Animals 
Male Wistar rats, weighing 180-370 g, which 
come from local colony, were used. Seven days 
before the experiments, the animals were housed, 
in number of five, in plastic cages with metallic 
cover (40 x 50 x 20cm) at a controlled room 
temperature (22 ± 2ºC), with a 12h light-dark 
cycle (the lights came on at 07:00). Water and 
food were available ad libitum. The animals were 
randomly divided into control and experimental 
groups. Behavioral tests on control and 
experimental rats were intermixed in order to 
minimizing circadian changes. All the 
observations were made between 08:00 and 18:00. 
The animals used in this study were maintained in 
accordance with the guidelines of the Committee 
on Care and Use of Laboratory Animal Resources, 
National Research Council, USA. 
 
Drugs 
Moxidectin (Cydectin - Fort Dodge Animal Health 
Ltd., Campinas) was diluted in sweet almond oil 
(Industrial Leclerc Ltd., São Paulo), obtaining the 
concentrations of 0.2, 2.0 and 20 mg/ml, just 
before subcutaneous (SC) injections of 1.0 ml/kg 
from one of these preparations. 
The lowest MXD dose employed was 0.2 mg/kg, 
i.e., a therapeutic dose widely used clinically in
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different animal species; the remaining doses, i.e., 
2.0 and 20.0 mg/kg were increased in a 
logarithmic scale. 
 
Open Field 
Sixty four male rats were divided into four groups: 
three experimental (n = 16 for each group; 0.2, 2.0 
or 20.0mg/kg of MXD) and one control (n = 16; 
1.0 ml/kg sweet almond oil), and tested in an open 
field. The open field apparatus was a round 
wooden arena, 970 mm in diameter and metallic 
wall, 280 mm of height, painted white, with the 
floor divided into 25 areas almost equal, 
delineated in black. During the experiment, three 
40W white bulbs hanging 720 mm from the floor 
provided continuous illumination of the arena. 
Hand-operated counters were employed to score 
locomotion (number of floor areas entered) and 
rearing frequencies (number of times that an 
animal stood on its hind legs) and a chronometer 
was used to measure the duration of immobility 
(total time without spontaneous movements). For 
open field observations, each rat was individually 
placed in the center of arena and its behavioral 
parameters were recorded over 3 min at 24 and 72 
h after the treatment. The rats returned to their 
home cage immediately after the observations. The 
animals of the control and experimental groups 
were observed at random. The open field 
apparatus was washed with a 5% ethanol solution 
before introduction of each animal in the arena, in 
order to eliminate any possible influences of smell 
left by previous subjects. 
 
Wooden Beam 
The motor coordination was evaluated through a 
new model, the wooden beam. This model was 
adapted from the one described by Jeffery and 
Blakemore (1997). The apparatus was a wooden 
beam, 18 mm in width and thickness and 2 m in 
length, with a 100 mm2 and 18 mm in thickness 
platform in each extremity. The beam had a 200 
mm height feet, at platforms and at center, painted 
white with two black vertical marks delimiting 1m 
in the central portion (Fig. 1). During the 
experiment, this beam was leaning on a balcony of 
the observation room. Thirty rats were used in the 
wooden beam test, divided in three experimental 
groups (n=10 for each group; 0.2, 2.0 or 20.0 
mg/kg of MXD). Initially, each rat was trained to 
walk on the beam, in 5 min daily sessions, in the 
following way: on the first day, positive 
reinforcement (small portion of condensed milk) 
was put on both platforms and, following, the rat 
was introduced to get used to the environment and 
to the reinforcement. Next day, the animal was put 
at beam, close to the platform with the 
reinforcement, with the head turned back to this. 
On the following days, the rat was put at beam, 
however, at more and more distant from the 
platform with reinforcement, until the animal 
crossed the beam, reaching the opposite platform 
and returned to the initial platform, always 
receiving the reinforcement at the end of each 
crossing. The training period (7 to 10 days) was 
considered complete when each rat could reliably 
cross the beam without stalling (four crossings), 
few footstep errors were made at this stage. The 
animals that were not capable to walk in the beam 
in 10 days were eliminated from the experiment. 
Once trained, the rats were submitted to three 
observation sessions (24 h before and 24, 72 h 
after the treatment). During each evaluation, a 
score (Table 1) was attributed for  each  step with 
the pelvic member, turned  for the observer,  when 
the rat walked in the central portion of beam (1m 
among the vertical marks) at each cross. At the 
end of each session, the scores obtained by each 
animal in the four crossings were added. Before 
each animal was tested, the wooden beam was 
cleaned with a cloth moistened in water and after 
that all the animals of each cage, with 5% ethanol 
solution.
 
 
Table 1 - Scores for the evaluation of the rat behavior at wooden beam (Jeffery and Blakemore, 1997). 
Score Foot Position 
0 Normal: foot positioned on top of beam, no slippage 
1 Minor error: foot slip so that part of the foot was visible below the lower surface of beam 
2 Major error: whole foot slipped below the lower surface of the beam 
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Determination of striatal neurotransmitters 
and metabolite levels 
Eighteen male rats were divided into two groups: 
the experimental (n = 9) received 0.2 mg/kg of 
MOX) and the control (n = 9) 1.0 ml/kg sweet 
almond oil). Rats treated with as without MOX 
were decapitated 72 h after the treatments. Brains 
were dissected on dry ice and prepared as 
described previously (Felicio et al., 1996). Briefly, 
the striatum was weighted and stored -70 °C. 
During the weeks following the sample collection, 
perchloric acid was added to the tissues, which 
were then homogenized by sonication one week 
before the neurochemical evaluations. Dopamine 
(DA) and its metabolites, homovanillic acid 
(HVA) and 3,4 dihydroxyphenylacetic acid 
(DOPAC) were measured by HPLC (Shimadzu, 
model 6A) with a C-1 column (Shimpak-ODS), an 
electrochemical detector (Shimadzu, model 6A), a 
sample injector (valve for 20 µl), and an integrator 
(Shimadzu, model 6A Chromatopac). GABA was 
measured by HPLC (HP, model 1100) with a 
Beckman 5 µ Ultrasphere ODS-PTH column, a 
sample injector (valve for 1.0 ml). Each sample 
was run for 25 min to DA and its metabolites and 
28 min to GABA. The limit of detection was 2 pg 
for DA, DOPAC and 20 pg for HVA and GABA. 
 
      1m 
      
 
  (A) 
 
10 cm 
                                                                                                                                            10 cm 
  (B) 
Figure1 - Scheme of wooden beam (thickness = 18 mm). (A) Lateral view and (B) superior view. 
 
 
Statistical Analysis 
The Bartlett test was used to evaluate the data 
homocedasticity. Analysis of variance (ANOVA), 
followed by Tukey-Kramer multiple comparisons 
test, was used to analyze the data from the open 
field test. The Friedman test for repeated 
measures, followed by the Dunn test for multiple 
comparisons was employed to the data from 
wooden beam test. The neurochemical data were 
analyzed by Mann-Whitney-U-test. In these 
experiments, p<0.05 was the criterion for 
statistical significance. 
 
 
RESULTS 
 
Fig. 2 shows the effects of the administration of 
the MXD in the general activity of rats observed in 
the open field. Although GABAB receptor agonist 
(baclofen) inhibited dose-dependently the 
locomotor activity (Agmo and Giordano, 1985; 
Nissbrandt and Engberg, 1996; Paredes et al., 
1997), in the current experiment, the ANOVA did 
not show significant differences in the locomotion 
frequencies (F24=0.90; F72=0.29; df=3/63, 
p>0.05) and rearing frequencies (F24=0.94; 
F72=1.79; df=3/63, p>0.05) among control and 
experimental groups. On the other hand, 
significant differences among the groups were 
observed in the immobility duration when the rats 
were observed after 72 h (F24=1.79; F72=5.23; 
df=3/63, p<0.05); the Tukey-Kramer test showed 
reduction in the duration of immobility of the 
animals that received 0.2 or 20 mg/kg of MXD, at 
the 72 h post-treatment, when compared to the 
animals of the control group. 
10 cm 2 m 
20 cm 
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Although MXD did not show significant effects on 
the locomotion frequencies, this was able to impair 
motor coordination of rats evaluated at the wooden 
beam (Fig. 3). Significant differences were 
observed in the sum of the scores of the rats that 
received 0.2 mg/kg (Fr=16.632, p<0.05), 2.0 
mg/kg (Fr=16.800, p<0.05) and 20 mg/kg 
(Fr=15.842, p<0.05) of MXD. The Dunn test of 
multiple comparisons showed that there was an 
increase in the sum of the scores after 24 and 72 h 
of the administration of the different doses of the 
drug, when compared to the sum of the scores 
obtained 24 h before the injection. At this time 
(base line), after the training, almost all rats were 
able to cross the beam with no error. 
Table 2 shows the effects of MXD on striatal 
GABA, dopamine and its metabolite levels. MXD 
treatment reduced the striatal dopamine and HVA 
levels. No differences were observed between 
MXD and controls in striatal GABAergic and 
DOPAC levels as well as in HVA/DA and 
DOPAC/DA ratios. 
 
 
 
DISCUSSION 
 
The behavioral observations were accomplished 
24 and 72 h after the administration of MXD, 
since post SC administration its Cmax were 
achieved 8 h post-treatment in cattle and had a 
half-life of 80 h (Lanusse et al, 1997; Joint 
FAO/WHO, 1995). MXD showed a long plasma 
residence time after an early peak concentration, 
followed by a fast decline (distribution phase) in 
the plasma concentration profile between the Cmax 
and 10 days post-treatment (Lanusse et al, 1997). 
In the present work, the possible effects of the 
MXD in the general activity of the rats observed in 
the open field were studied. General activity is an 
index for evaluating behavioral changes induced in 
animals, not only by physiological and genetic 
manipulation, but also by toxicological ones. 
Among the techniques used to assess general 
activity, open field techniques stand out, making it 
possible to measure various behavioral parameters, 
among which are those related to emotional, 
exploratory and motor behavior. 
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Figure 2 - The effects of moxidectin (MXD) on general activity of rats observed in open field. Data are 
means + standard errors of mean. *p<0.05, ANOVA and Tukey-Kramer (in relation to control 
group). 
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Table 2 - The effects of moxidectin (MXD) on striatal GABA, dopamine and its metabolite levels (ng/g tissue). 
Animals were treated with 0.2 mg/kg MXD, 72 h. before the assay. Data are means ± standard errors of mean. N = 9 
per group. 
 Groups 
 Control MXD (0.2 mg/kg) 
GABA 905.50 ± 163.13 778.45 ± 146.55 
DA 3,511.90 ± 638.91 1,537.30 ± 397.69*  
HVA 141.24 ± 24.02 73.20 ± 17.41*  
DOPAC 204.66 ± 39.08 119.04 ± 28.39 
HVA/DA 0.040 ± 0.006 0.058 ± 0.007 
DOPAC/DA 0.006 ± 0.008 0.008 ± 0.010 
*p<0.05, in relation to control group. Mann-Whitney U-test. 
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Figure 3 - The effects of moxidectin (MXD) on motor coordination of rats evaluated at wooden 
beam. Data are medians of the sum of errors for the four crossings obtained 24 h before 
(-24) and 24 and 72 h after the treatment. *p<0.05, Friedman test and Dunn test (in 
relation to -24 h group). 
 
 
The first exposure of the animal to the device has a 
sharper emotional component than the remaining 
agents of exposure (Moniz et al., 1994; Batatinha 
et al., 1995; Massoco et al., 1995). This method 
provides a direct behavioral observation and is 
very much used in psycho-pharmacology studies 
of animals, because it is simple and is available for 
a fast and easy measure of the several behaviors 
that can be clearly defined. The general activity 
measured in the open field can be useful to define 
the doses, administration ways and the latency to 
the effect of a chemical substance to be studied. 
Locomotion by the rat in an open field is inversely 
associated with anxiety ratings, depending upon 
whether the locomotion appears purposeful and 
whether the animal exhibits other exploratory 
behaviors such as rearing or approaching the 
center of the open field, in contrast to exhibiting 
anxiety-related behaviors such as hesitant 
locomotion, freezing, shivering, and defecation 
(Dishman et al., 1996). As the GABAergic drugs 
are ansiolitcs, the rats of this study that received 
0.2 or 20 mg/kg of MXD and were observed 72 h 
after the injections, showed significant reduction 
of immobility when compared with the rats of 
control group, and a loss of anxiety was noticed. 
The lack of effect of 2.0 mg/kg of MXD may be 
due to biphasic action of GABAergic drugs (Lloyd 
and Morselli, 1987; Car and Wisniewski, 1998; 
Silva et al., 2005). 
In this experiment, just a few of significant 
alterations were detected after the drug 
administration. This indicated that, even in high 
doses, MXD did not modify the rat's exploration 
behaviors in the open field, showing just a weak 
motor inhibition effect. On the other hand, MDX 
was able to impair the motor coordination of the 
animals observed at the wooden beam. 
The animal’s immobility in the open field and the 
impairment of motor coordination presented an 
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inversed-U-shape profile 72 h after the treatments, 
and not in the classical dose-response curve. It is 
possible that both facts expressed the motor 
impairment induced by MXD. Additionally, even 
in a therapeutic dose widely used clinically in 
different animal species, the motor incoordination 
was observed. 
It is well established that most neurons located 
within the striatum are GABAergic. The firing 
pattern of nigral dopaminergic neurons would be 
modulated differentially by disinhibition of 
GABAA inputs arising from substantia nigra pars 
reticulata and disinhibition of pallidonigral 
GABAergic inputs mediated by GABAB receptors 
(Tepper et al., 1995). Tegnér et al. (1993) 
observed that in the lamprey brain stem-spinal 
cord, a model system to study how the neuronal 
networks controlling motor behavior in 
vertebrates, both receptors, GABAA and GABAB, 
showed a modulator role, i.e, they acted together 
in the coordination of the locomotion. Kriem et al. 
(1998) found that GABAergic transmission in the 
substantia nigra pars reticulata (SNR), and not in 
the substantia nigra pars compacta (SNC), would 
play a crucial role in the control of motor activity 
of rats exposed to high pressure, and the GABAA 
and GABAB receptors, in SNR, had an opposite 
role in the regulation of the movements. It has 
been shown that both the receptors, GABAA and 
GABAB, have a modulator role in the control of 
locomotion, and they have an opposite roles in the 
regulation of this behavior (Tegnér et al., 1993; 
Kriem et al., 1998). It is also known that the 
stimulation of GABAB receptor reduces the 
locomotor activity and GABAA receptor is not 
involved in the locomotion-reducing effect (Agmo 
and Giordano, 1985; Paredes et al., 1997). The 
effective doses of some GABAergic drugs that 
impair motor execution, reduce ambulatory 
activity and frequently also motor coordination, as 
evaluated by open field activity and a treadmill 
test (Dishman et al., 1996). The present results 
showing a significant decrease on striatal 
dopaminergic system activity suggested that MXD 
should activate the GABAergic system, resulting 
in a reduced motor coordination in consequence of 
inhibition of striatal dopamine release. In fact, not 
only the dopamine levels were decreased but also 
its metabolite levels, the HVA. 
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RESUMO 
 
A moxidectina (MXD) é uma droga antiparasitária 
amplamente empregada em animais domésticos; 
seu mecanismo de ação, em mamíferos, envolve o 
neurotransmissor ácido gama-aminobutírico 
(GABA). Esse neurotransmissor tem papel 
importante na função motora. Assim, no presente 
trabalho estudaram-se os efeitos da MXD em 
alguns parâmetros comportamentais ligados a 
função motora de ratos e também em sistemas de 
neurotransmissão central. A atividade geral no 
campo aberto e a coordenação motora na trave 
elevada foram empregadas para avaliar os efeitos 
de diferentes doses de MXD. Os resultados 
mostraram que: no campo aberto, mesmo as doses 
maiores (2.0 e 20.0 mg/kg) de MXD não alteraram 
as freqüências de locomoção e levantar. Por outro 
lado, a MXD foi capaz de prejudicar a 
coordenação motora dos animais avaliada na trave 
elevada. Estudos neuroquímicos dos níveis 
estriatais de GABA e dopamina mostraram 
redução dos níveis de dopamina e seu metabólito, 
ácido homavanílico, sem interferência nos níveis 
de GABA estriatal. Considerando que a 
estimulação de receptores GABAérgicos tem 
efeito inibidor sobre o sistema dopaminérgico 
estriatal, nós atribuímos a redução na coordenação 
motora a ação da MXD sobre o sistema 
dopaminérgico via ativação do GABA. 
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